Skip to content

Pilot Trial of the Robotic Uterine Manipulator

Pilot Trial of the Robotic Uterine Manipulator

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03517228
Enrollment
28
Registered
2018-05-07
Start date
2018-04-24
Completion date
2023-12-12
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Surgery

Keywords

Robotic Uterine Manipulator, 18-173

Brief summary

The purpose of this study is to test a robotic uterine manipulator system called the Barakat Automated Uterine Manipulator (BAUM), which will assist the surgeon in moving and positioning the uterus during a hysterectomy. This new device will allow the surgeon to control the movements of the robotic arm directly instead of giving verbal instructions to a staff member. The BAUM has never been used during surgeries before this trial. Overall, the study goal is to determine whether the use of this robotic uterine manipulator system can be safely used in the operating room while improving surgeon control during the procedure.

Interventions

DEVICEBAUM device

The robotic manipulator will be placed at the start of each case. The manipulator will be cleaned and sanitized using the same process as other reusable OR devices. Feasibility will be determined by the rate of successful robotic manipulator docking and if the manipulation of the uterus was successful for the duration of the procedure. The V-Care is an FDA approved uterine manipulator which will attach to the investigational BAUM. Placement of a BAUM will be noted on the operative note.

Sponsors

Northwell Health
CollaboratorOTHER
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female participant must be scheduled for a total laparoscopic or robotic-assisted hysterectomy for a gynecologic condition * Female participants must be 18 years of age or older

Exclusion criteria

* Female participant is not eligible if the surgeon does not plan to use a uterine manipulator

Design outcomes

Primary

MeasureTime frameDescription
the Number of Intraoperative Complications Attributed to the Robotic Manipulator.25- 35 dayswill be assessed by reporting all intraoperative complications during the surgery. Complications might include vaginal tear or uterine perforation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Total Laparoscopic or Robotic-assisted Hysterectomy
All patients who are consented for a total laparoscopic or robotic-assisted hysterectomy will be eligible for the trial, unless the surgeon does not plan to use a uterine manipulator. BAUM device: The robotic manipulator will be placed at the start of each case. The manipulator will be cleaned and sanitized using the same process as other reusable OR devices. Feasibility will be determined by the rate of successful robotic manipulator docking and if the manipulation of the uterus was successful for the duration of the procedure. The V-Care is an FDA approved uterine manipulator which will attach to the investigational BAUM. Placement of a BAUM will be noted on the operative note.
28
Total28

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAnatomy issue - abandoned prior to surgery1
Overall StudyCanceled due to device being updated1
Overall StudyHard drive issues, abandoned prior to surgery2
Overall StudyNo V Cares in stock1
Overall StudyService issue, use of device cancelled prior to surgery2
Overall StudySurgery was at MAIN, could not change location to JOSIE1
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicTotal Laparoscopic or Robotic-assisted Hysterectomy
Age, Continuous57 years
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
24 Participants
Region of Enrollment
United States
28 Participants
Sex: Female, Male
Female
28 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
3 / 28
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

the Number of Intraoperative Complications Attributed to the Robotic Manipulator.

will be assessed by reporting all intraoperative complications during the surgery. Complications might include vaginal tear or uterine perforation.

Time frame: 25- 35 days

ArmMeasureValue (NUMBER)
Total Laparoscopic or Robotic-assisted Hysterectomythe Number of Intraoperative Complications Attributed to the Robotic Manipulator.0 # of intraoperative complications

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026